About: Blood glucose levels and COVID-19. Reply to Sardu C, D’Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Blood glucose levels and COVID-19. Reply to Sardu C, D’Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter] Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Blood glucose levels and COVID-19. Reply to Sardu C, D’Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]
Creator	Robert, René Al-Salameh, Abdallah Allix, Ingrid Amadou, Coralie Arnault, Gwénaëlle Baudoux, Florence Bauduceau, Bernard Cariou, Bertrand Hadjadj, Samy Kerlan, Véronique Laviolle, Bruno Marchand, Lucien Meyer, Laurent Pichelin, Matthieu Potier, Louis Prevost, Gaëtan Riveline, Jean-Pierre Saulnier, Pierre-Jean Sultan, Ariane Wargny, Matthieu
Source	Medline; PMC
abstract	covid:64ecbc352880260f15336315a73b65c0a48d4a1b#abstract
has issue date	2020-08-20(xsd:dateTime)
bibo:doi	10.1007/s00125-020-05255-9
bibo:pmid	32816095
has license	no-cc
sha1sum (hex)	64ecbc352880260f15336315a73b65c0a48d4a1b
schema:url	https://doi.org/10.1007/s00125-020-05255-9
resource representing a document's title	Blood glucose levels and COVID-19. Reply to Sardu C, D’Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]
has PubMed Central identifier	PMC7438680
has PubMed identifier	32816095
schema:publication	Diabetologia
resource representing a document's body	covid:64ecbc352880260f15336315a73b65c0a48d4a1b#body_text
is schema:about of	named entity 'blood glucose concentration' named entity 'COVID-19' named entity 'COVID-19' named entity 'blood glucose' named entity 'Novartis' named entity 'Sanofi' named entity 'risk of death' named entity 'ICU' named entity 'Novartis' named entity 'CAP' named entity 'Amgen' named entity 'peer-reviewed' named entity 'Medtronic' named entity 'AstraZeneca' named entity 'Novo Nordisk' named entity 'Bayer' named entity 'blood glucose' named entity 'hyperglycaemia' named entity 'Novo Nordisk' named entity 'Italian' named entity 'insulin' named entity 'severe pneumonia' named entity 'AstraZeneca' named entity 'treatment of patients' named entity 'Gilead' named entity 'AstraZeneca' named entity 'AstraZeneca' named entity 'Diabetes' named entity 'Servier' named entity 'prognosis' named entity 'randomised controlled trials' named entity 'blood glucose control' named entity 'C-reactive protein' named entity 'Novo Nordisk' named entity 'blood glucose' named entity 'blood glucose' named entity 'Novo Nordisk' named entity 'lymphocyte' named entity 'Eli Lilly' named entity 'Medtronic' named entity 'Lilly' named entity 'blood glucose' named entity 'Servier' named entity 'diabetes' named entity 'Eli Lilly' named entity 'Sanofi' named entity 'mmol/l' named entity 'Eli Lilly' named entity 'clinical investigations' named entity 'Novo Nordisk' named entity 'Pierre Fabre' named entity 'Sanofi' named entity 'AstraZeneca' named entity 'COVID-19' named entity 'Novo Nordisk' named entity 'multivariable analysis' named entity 'Sanofi' named entity 'blood glucose' named entity 'COVID' named entity 'Gilead' named entity 'AstraZeneca' named entity 'Novo Nordisk'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software